{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:35:06Z","timestamp":1785810906102,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07745-7","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:45:12Z","timestamp":1769870712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monocyte-to-HDL ratio (MHR) is associated with overall and renal mortality in community-dwelling older individuals with chronic kidney disease (CKD)"],"prefix":"10.1186","volume":"24","author":[{"given":"Guido","family":"Gembillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0171-3358","authenticated-orcid":false,"given":"Luca","family":"Soraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Filice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Biscetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Chinig\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Muglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Princiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Lattanzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edlin","family":"Villalta Savedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Corsonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"7745_CR1","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.kint.2024.03.020","volume":"105","author":"G Wong","year":"2024","unstructured":"Wong G, Bernier-Jean A, Rovin B, Ronco P. Time for action: recognizing chronic kidney disease as a major noncommunicable disease driver of premature mortality. Kidney Int. 2024;105:1144\u20136.","journal-title":"Kidney Int"},{"key":"7745_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.ajkd.2025.01.012","volume":"86","author":"CP Walther","year":"2025","unstructured":"Walther CP, Gregg LP, Navaneethan SD. Cardiovascular disease risk estimates in the US CKD population using the PREVENT equation. Am J Kidney Dis. 2025;86:10\u20137.","journal-title":"Am J Kidney Dis"},{"key":"7745_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41581-024-00863-9","volume":"20","author":"NC Chesnaye","year":"2024","unstructured":"Chesnaye NC, Ortiz A, Zoccali C, Stel VS, Jager KJ. The impact of population ageing on the burden of chronic kidney disease. Nat Rev Nephrol. 2024;20:569\u201385.","journal-title":"Nat Rev Nephrol"},{"key":"7745_CR4","doi-asserted-by":"crossref","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023;12.","DOI":"10.3390\/cells12121581"},{"key":"7745_CR5","doi-asserted-by":"crossref","unstructured":"Petreski T, Piko N, Ekart R, Hojs R, Bevc S. (2021). Review on inflammation markers in chronic kidney disease. 9:182.","DOI":"10.3390\/biomedicines9020182"},{"key":"7745_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12967-023-04509-5","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang L, Zhang W, Tang M, Cui H, Wu X, et al. Understanding the relationship between Circulating lipids and risk of chronic kidney disease: a prospective cohort study and large-scale genetic analyses. J Translational Med. 2023;21:671.","journal-title":"J Translational Med"},{"key":"7745_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.athplu.2023.04.001","volume":"52","author":"C Pavanello","year":"2023","unstructured":"Pavanello C, Ossoli A. HDL and chronic kidney disease. Atheroscler Plus. 2023;52:9\u201317.","journal-title":"Atheroscler Plus"},{"key":"7745_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/j.ajkd.2017.06.011","volume":"71","author":"MB Lanktree","year":"2018","unstructured":"Lanktree MB, Th\u00e9riault S, Walsh M, Par\u00e9 G. HDL Cholesterol, LDL Cholesterol, and triglycerides as risk factors for CKD: a Mendelian randomization study. Am J Kidney Dis. 2018;71:166\u201372.","journal-title":"Am J Kidney Dis"},{"key":"7745_CR9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jacl.2018.03.085","volume":"12","author":"SD Navaneethan","year":"2018","unstructured":"Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, et al. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018;12:1061\u2013e10711067.","journal-title":"J Clin Lipidol"},{"key":"7745_CR10","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1002\/jcp.27028","volume":"233","author":"S Ganjali","year":"2018","unstructured":"Ganjali S, Gotto AM Jr., Ruscica M, Atkin SL, Butler AE, Banach M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233:9237\u201346.","journal-title":"J Cell Physiol"},{"key":"7745_CR11","doi-asserted-by":"publisher","first-page":"300060521105886","DOI":"10.1177\/03000605211058861","volume":"49","author":"D Kim","year":"2021","unstructured":"Kim D, Kim DW, Lee YH, Park SY, Song YW, Shin H, et al. Relationships between monocyte count to high-density lipoprotein cholesterol ratio and cardiovascular outcomes in patients commencing Dialysis. J Int Med Res. 2021;49:3000605211058861.","journal-title":"J Int Med Res"},{"key":"7745_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11255-021-02904-9","volume":"54","author":"G Gembillo","year":"2022","unstructured":"Gembillo G, Siligato R, Cernaro V, Satta E, Conti G, Salvo A, et al. Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients. Int Urol Nephrol. 2022;54:395\u2013403.","journal-title":"Int Urol Nephrol"},{"key":"7745_CR13","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11255-014-0730-1","volume":"46","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46:1619\u201325.","journal-title":"Int Urol Nephrol"},{"key":"7745_CR14","doi-asserted-by":"publisher","first-page":"2331614","DOI":"10.1080\/0886022X.2024.2331614","volume":"46","author":"L Xu","year":"2024","unstructured":"Xu L, Li D, Song Z, Liu J, Zhou Y, Yang J, et al. The association between monocyte to high-density lipoprotein cholesterol ratio and chronic kidney disease in a Chinese adult population: a cross-sectional study. Ren Fail. 2024;46:2331614.","journal-title":"Ren Fail"},{"key":"7745_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12944-024-02149-2","volume":"23","author":"J Lin","year":"2024","unstructured":"Lin J, Li Z, Xu J, Pan M, Yin T, Wang J, et al. Independent and joint associations of monocyte to high-density lipoprotein-cholesterol ratio and body mass index with cardiorenal syndrome: insights from NHANES 2003\u20132020. Lipids Health Dis. 2024;23:153.","journal-title":"Lipids Health Dis"},{"key":"7745_CR16","doi-asserted-by":"crossref","unstructured":"Song J, Xu Z, Yu H, Li A, Liu Y, Jin M. (2025). Association of three composite inflammatory and lipid metabolism indicators with cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES 1999\u20132020. Mediat Inflamm. 2025:6691516.","DOI":"10.1155\/mi\/6691516"},{"key":"7745_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12967-024-04895-4","volume":"22","author":"D Wu","year":"2024","unstructured":"Wu D, Chen G, Lan Y, Chen S, Ding X, Wei C, et al. Measurement of cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio in the risk prediction of type 2 diabetes: a prospective cohort study. J Translational Med. 2024;22:110.","journal-title":"J Translational Med"},{"key":"7745_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1186\/s12967-025-07028-7","volume":"23","author":"D Wu","year":"2025","unstructured":"Wu D, Lan Y, Ding X, Balmer L, Li X, Wang W, et al. Imbalances in Circulating monocyte and high-density lipoprotein cholesterol exacerbates the residual risk of incident myocardial infarction beyond LDL-C: a real-life, prospective cohort study. J Translational Med. 2025;23:1433.","journal-title":"J Translational Med"},{"key":"7745_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12872-023-03461-y","volume":"23","author":"G Pei","year":"2023","unstructured":"Pei G, Liu R, Wang L, He C, Fu C, Wei Q. Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases. BMC Cardiovasc Disord. 2023;23:451.","journal-title":"BMC Cardiovasc Disord"},{"key":"7745_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1186\/s12967-025-06755-1","volume":"23","author":"S Tian","year":"2025","unstructured":"Tian S, Li Z, Bi Y, Che X, Feng A, Wang Y. Identifying pathways to cardiovascular mortality by causal graphical models and mediation analysis among hypertensive patients: insights from a prospective study. J Translational Med. 2025;23:690.","journal-title":"J Translational Med"},{"key":"7745_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12944-022-01638-6","volume":"21","author":"M Jiang","year":"2022","unstructured":"Jiang M, Yang J, Zou H, Li M, Sun W, Kong X. Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the united States. Lipids Health Dis. 2022;21:30.","journal-title":"Lipids Health Dis"},{"key":"7745_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/ije\/dyu067","volume":"43","author":"A Sonnega","year":"2014","unstructured":"Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JW, Weir DR. Cohort profile: the health and retirement study (HRS). Int J Epidemiol. 2014;43:576\u201385.","journal-title":"Int J Epidemiol"},{"key":"7745_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.7326\/0003-4819-157-7-201210020-00003","volume":"157","author":"ES Schaeffner","year":"2012","unstructured":"Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012;157:471\u201381.","journal-title":"Ann Intern Med"},{"key":"7745_CR24","doi-asserted-by":"crossref","unstructured":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117\u2013314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"7745_CR25","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the united States. JAMA. 2007;298:2038\u201347.","journal-title":"JAMA"},{"key":"7745_CR26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","volume":"5","author":"M Sampson","year":"2020","unstructured":"Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A new equation for calculation of Low-Density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia. JAMA Cardiol. 2020;5:540\u20138.","journal-title":"JAMA Cardiol"},{"key":"7745_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.hlc.2016.02.023","volume":"25","author":"MS Cetin","year":"2016","unstructured":"Cetin MS, Ozcan Cetin EH, Kalender E, Aydin S, Topaloglu S, Kisacik HL, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016;25:1077\u201386.","journal-title":"Heart Lung Circ"},{"key":"7745_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1230719","volume":"339","author":"FK Swirski","year":"2013","unstructured":"Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013;339:161\u20136.","journal-title":"Science"},{"key":"7745_CR29","doi-asserted-by":"crossref","unstructured":"Nikolic-Paterson DJ, Wang S, Lan HY. (2014). Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl. 2011;4:34\u201338.","DOI":"10.1038\/kisup.2014.7"},{"key":"7745_CR30","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","volume":"371","author":"A Rohatgi","year":"2014","unstructured":"Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371:2383\u201393.","journal-title":"N Engl J Med"},{"key":"7745_CR31","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1172\/JCI42946","volume":"121","author":"C Besler","year":"2011","unstructured":"Besler C, Heinrich K, Rohrer L, Doerries C, Riwanto M, Shih DM, et al. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest. 2011;121:2693\u2013708.","journal-title":"J Clin Invest"},{"key":"7745_CR32","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868\u201374.","journal-title":"Nature"},{"key":"7745_CR33","doi-asserted-by":"crossref","unstructured":"Marsche G, Heine GH, Stadler JT, Holzer M. Current Understanding of the relationship of HDL Composition, structure and function to their cardioprotective properties in chronic kidney disease. Biomolecules. 2020. 10.","DOI":"10.3390\/biom10091348"},{"key":"7745_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11606-010-1511-x","volume":"26","author":"LS Dalrymple","year":"2011","unstructured":"Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;26:379\u201385.","journal-title":"J Gen Intern Med"},{"key":"7745_CR35","doi-asserted-by":"publisher","first-page":"e0193734","DOI":"10.1371\/journal.pone.0193734","volume":"13","author":"J Wang","year":"2018","unstructured":"Wang J, Wang F, Saran R, He Z, Zhao MH, Li Y, et al. Mortality risk of chronic kidney disease: A comparison between the adult populations in urban China and the united States. PLoS ONE. 2018;13:e0193734.","journal-title":"PLoS ONE"},{"key":"7745_CR36","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"CKDP Consortium","year":"2023","unstructured":"Consortium CKDP. Estimated glomerular filtration Rate, Albuminuria, and adverse outcomes: an Individual-Participant data Meta-Analysis. JAMA. 2023;330:1266\u201377.","journal-title":"JAMA"},{"key":"7745_CR37","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ki.2010.550","volume":"79","author":"BC Astor","year":"2011","unstructured":"Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331\u201340.","journal-title":"Kidney Int"},{"key":"7745_CR38","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"7745_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12967-024-06058-x","volume":"23","author":"C Huimin","year":"2025","unstructured":"Huimin C, Yuxin Z, Peng W, Wei G, Hong L, Na L, et al. Bioinformatics analysis and experimental validation of potential targets and pathways in chronic kidney disease associated with renal fibrosis. J Transl Med. 2025;23:387.","journal-title":"J Transl Med"},{"key":"7745_CR40","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s12967-025-06574-4","volume":"23","author":"L Zhao","year":"2025","unstructured":"Zhao L, Zhang Y, Wang R, Yang J, Wu R, Wu Z, et al. Engineered macrophage membrane-coated Dihydroartemisinin nanoparticles with enhanced CCR2 expression improved symptoms in MRL\/LPR mice by metabolic reprogramming of Proinflammatory macrophages. J Transl Med. 2025;23:608.","journal-title":"J Transl Med"},{"key":"7745_CR41","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1186\/s12967-025-07350-0","volume":"23","author":"S Chai","year":"2025","unstructured":"Chai S, Zeng Z, Shang J, Xu Y, Han X, Ma B, et al. Histone modification-mediated epigenetic regulation in AKI-to-CKD transition: a cell-type-specific perspective. J Transl Med. 2025;23:1346.","journal-title":"J Transl Med"},{"key":"7745_CR42","doi-asserted-by":"crossref","unstructured":"Go Alan S, Chertow Glenn M, Fan D, McCulloch Charles E, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 351:1296\u2013305.","DOI":"10.1056\/NEJMoa041031"},{"key":"7745_CR43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3:514\u201325.","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07745-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07745-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07745-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:47:29Z","timestamp":1772189249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07745-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7745"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07745-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHANES is approved by the National Center for Health Statistics Research Ethics Review Board, and all participants provided written consent. The HRS and HRS-VBS were approved by the Health Sciences and Behavioral Sciences institutional review board at the University of Michigan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"300"}}